Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported) August 5, 2004
BARR PHARMACEUTICALS, INC.
| Delaware | 1-9860 | 42-1612474 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||
| 400 Chestnut Ridge Road, Woodcliff Lake, NJ |
07677 | |||
| (Address of principal executive offices) |
(Zip code) | |||
(201) 930-3300
| Item 12. Results of Operations and Financial Condition. | ||||||||
| SIGNATURES | ||||||||
| PRESS RELEASE | ||||||||
Table of Contents
Exhibit 99.0
Item 12. Results of Operations and Financial Condition.
On August 5, 2004, Barr Pharmaceuticals, Inc. (the “Company”) issued a press release announcing results for the three and twelve months ended June 30, 2004. A copy of the release is attached hereto as Exhibit 99.0 and is incorporated herein by reference.
The Company hosted a conference call and webcast at 8:30 a.m. Eastern time on Thursday, August 5th to discuss the results. A replay of the conference will be available from 12 Noon Eastern time on August 5th through 11:59 p.m. Eastern time on August 7th, and can be accessed by dialing (800) 475-6701 in the United States or (320) 365-3844 internationally and using access code 739264. A replay of the webcast is available on the Company’s website at www.barrlabs.com in the Investor Relations / Calendar of Events section.
| Exhibit Number |
Exhibit |
|
99.0
|
Barr Pharmaceuticals, Inc. August 5, 2004 earnings release. |
Table of Contents